Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 9 studies | 52% ± 14% | |
adipocyte | 4 studies | 34% ± 11% | |
hepatocyte | 4 studies | 50% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 5 studies | 25% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 8308.49 | 89 / 89 | 81% | 76.26 | 731 / 901 |
liver | 97% | 8989.35 | 220 / 226 | 66% | 54.52 | 268 / 406 |
adipose | 85% | 495.90 | 1020 / 1204 | 0% | 0 | 0 / 0 |
breast | 78% | 441.05 | 359 / 459 | 1% | 0.07 | 8 / 1118 |
peripheral blood | 11% | 35.53 | 98 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 7% | 12.58 | 95 / 1335 | 0% | 0 | 0 / 0 |
skin | 7% | 4.99 | 124 / 1809 | 0% | 0 | 0 / 472 |
heart | 3% | 2.24 | 27 / 861 | 0% | 0 | 0 / 0 |
intestine | 2% | 1.58 | 19 / 966 | 0% | 0.07 | 1 / 527 |
thymus | 2% | 1.54 | 13 / 653 | 0% | 0 | 0 / 605 |
muscle | 2% | 1.04 | 13 / 803 | 0% | 0 | 0 / 0 |
esophagus | 2% | 1.50 | 23 / 1445 | 0% | 0 | 0 / 183 |
adrenal gland | 1% | 0.44 | 3 / 258 | 0% | 0 | 0 / 230 |
uterus | 1% | 0.25 | 1 / 170 | 0% | 0.02 | 1 / 459 |
pancreas | 1% | 0.22 | 2 / 328 | 0% | 0 | 0 / 178 |
ovary | 1% | 0.66 | 1 / 180 | 0% | 0 | 0 / 430 |
lung | 1% | 0.29 | 3 / 578 | 0% | 0 | 0 / 1155 |
spleen | 0% | 7.48 | 1 / 241 | 0% | 0 | 0 / 0 |
stomach | 0% | 0.15 | 1 / 359 | 0% | 0 | 0 / 286 |
brain | 0% | 0.02 | 1 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032787 | Biological process | monocarboxylic acid metabolic process |
GO_0009636 | Biological process | response to toxic substance |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0006637 | Biological process | acyl-CoA metabolic process |
GO_0006544 | Biological process | glycine metabolic process |
GO_1901787 | Biological process | benzoyl-CoA metabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0047962 | Molecular function | glycine N-benzoyltransferase activity |
GO_0016746 | Molecular function | acyltransferase activity |
GO_0047961 | Molecular function | glycine N-acyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GLYAT |
Protein name | Glycine-N-acyltransferase Glycine N-acyltransferase (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase) (AAc) (Aralkyl acyl-CoA N-acyltransferase) (Aralkyl acyl-CoA:amino acid N-acyltransferase) (Benzoyl-coenzyme A:glycine N-acyltransferase) (Glycine N-benzoyltransferase) (EC 2.3.1.71) (HRP-1(CLP)) |
Synonyms | CAT ACGNAT GAT |
Description | FUNCTION: Mitochondrial acyltransferase which transfers an acyl group to the N-terminus of glycine and glutamine, although much less efficiently. Can conjugate numerous substrates to form a variety of N-acylglycines, with a preference for benzoyl-CoA over phenylacetyl-CoA as acyl donors. Thereby detoxify xenobiotics, such as benzoic acid or salicylic acid, and endogenous organic acids, such as isovaleric acid. . |
Accessions | ENST00000344743.8 [Q6IB77-1] K7ES21 ENST00000586098.1 ENST00000611865.4 [Q6IB77-1] Q6IB77 ENST00000529732.5 [Q6IB77-1] ENST00000278400.3 [Q6IB77-2] |